PRTK
Paratek Pharmaceuticals, Inc.
PRTK
PRTK
Delisted
PRTK was delisted on the 20th of September, 2023.
66 hedge funds and large institutions have $47M invested in Paratek Pharmaceuticals, Inc. in 2023 Q2 according to their latest regulatory filings, with 21 funds opening new positions, 12 increasing their positions, 19 reducing their positions, and 17 closing their positions.
Holders
66
Holders Change
+3
Holders Change %
+4.76%
% of All Funds
1.04%
Holding in Top 10
–
Holding in Top 10 Change
-1
Holding in Top 10 Change %
-100%
% of All Funds
–
New
21
Increased
12
Reduced
19
Closed
17
Calls
$146K
Puts
$260K
Net Calls
-$114K
Net Calls Change
-$252K
Top Buyers
1 |
NM
1
Newtyn Management
New York
|
$1.69M |
2 |
EP
2
Eversept Partners
New York
|
$2.93M |
3 |
N
3
Natixis
Paris,
France
|
$1.09M |
4 |
PAMP
4
Polar Asset Management Partners
Toronto,
Ontario, Canada
|
$1.06M |
5 |
5
Two Sigma Investments
New York
|
$913K |